Evidence map›Paper›PMID 35340878›Full record

ArticleExperimental and therapeutic medicine2022

Effects of vitamin D with or without calcium on pathological ossification: A retrospective clinical study.

Libin Liang, Tong Tong, Luyang Qin, Jing Xie, Yanping Xu, Yuguo Qin, Lansen Zhang, Dehui Liu, Xiaoyun Niu, Xinglong Tong

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Libin LiangHebei Xinglong Institute of Pharmaceutical and Medical Science, Shijiazhuang, Hebei 050091, P.R. China.
Tong TongDepartment of Spine Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China.
Luyang QinSchool of Clinical Medicine, North China University of Science and Technology, Tangshan, Hebei 063210, P.R. China.
Jing XieGraduate School, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China.
Yanping XuHebei Xinglong Institute of Pharmaceutical and Medical Science, Shijiazhuang, Hebei 050091, P.R. China.
Yuguo QinHebei Xinglong Institute of Pharmaceutical and Medical Science, Shijiazhuang, Hebei 050091, P.R. China.
Lansen ZhangHebei Xinglong Institute of Pharmaceutical and Medical Science, Shijiazhuang, Hebei 050091, P.R. China.
Dehui LiuHebei Xinglong Institute of Pharmaceutical and Medical Science, Shijiazhuang, Hebei 050091, P.R. China.
Xiaoyun NiuHebei Xinglong Institute of Pharmaceutical and Medical Science, Shijiazhuang, Hebei 050091, P.R. China.
Xinglong TongHebei Xinglong Institute of Pharmaceutical and Medical Science, Shijiazhuang, Hebei 050091, P.R. China.
Hebei Medical University · CNNorth China University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D protects against the development and severity of several rheumatic diseases. However, the effect of vitamin D on the pathological ossification associated with rheumatic diseases remains unknown. The present retrospective study analyzed the clinical outcomes of vitamin D without calcium compared with vitamin D with calcium on pathological ossification in joints and ligaments. Data were collected from patients who were diagnosed with osteoarthritis, rheumatoid arthritis or spondylarthritis, and the presence of pathological ossification in joints or ligaments was confirmed by X-ray, computed tomography or magnetic resonance imaging examination. A total of 2,965 patients aged 18-75 years old were included, among who, 1,725 were included in the vitamin D alone group and 1,240 in the vitamin D with calcium group. Vitamin D was administered intramuscularly (300,000 IU) once every 7-10 days, 4-6 times in total. Patients who ingested an oral calcium supplement (1,000 mg/day; ≥5 days/week) were considered the vitamin D with calcium group. The clinical outcome was evaluated based on the imaging changes of pathological ossification, which were classified as alleviation, aggravation and unchanged. The bone mineral density (BMD) was determined, and the calcium concentration in the serum and urine was measured. The results revealed that vitamin D alone alleviated pathological ossification, while vitamin D combined with calcium aggravated pathological ossification in the majority of patients (P<0.0001) independent of disease type and patient age. BMD measurements demonstrated a decreasing trend in the vitamin D alone group, whereas they exhibited an increasing trend in the vitamin D combined with calcium group. The urine calcium concentration increased after vitamin D treatment alone. Therefore, it was concluded that vitamin D exerted both pro-resorptive and anti-resorptive actions on pathological ossification. The bidirectional action of vitamin D on bone metabolism may depend on exogenous calcium supplementation.

Indexed as

bone mineral densitycalcium supplementationpathological ossificationvitamin D

Identifiers

PMID35340878
PMCPMC8931622
OpenAlexW4213342335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.